Assignee
IMMUNE SYSTEM KEY LTD
IL·3 granted patents·3 pending applications·3 citations·filing 2007–2023
Top patents by PatentIndex Score
6 records- 0169US9878015B2Pharmaceutical compositions and methods for the treatment of metastatic cancerIMMUNE SYSTEM KEY LTD·Filed 2014·Granted Jan 30, 2018·3 cites·6 claims
- 0264US11813305B2Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancerIMMUNE SYSTEM KEY LTD·Filed 2021·Granted Nov 14, 2023·0 cites·7 claims
- 0359US10933117B2Endoplasmic reticulum stress as a predictive tool in cancer therapy and a combination therapy for the treatment of cancerIMMUNE SYSTEM KEY LTD·Filed 2018·Granted Mar 2, 2021·0 cites·8 claims
- 0456US2025268985A1Bcl2 inhibitor and peptide combination therapy for treating proliferative diseasesIMMUNE SYSTEM KEY LTD·Filed 2023·Application pending·0 cites
- 0550US2024009277A1Polypeptides for use in the treatment and prevention of neurodegenerative diseasesIMMUNE SYSTEM KEY LTD·Filed 2021·Application pending·0 cites
- 0641US2010204097A1Therapeutic methods using a thymus peptideIMMUNE SYSTEM KEY LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNE SYSTEM KEY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →